journal article·2021-01

Antibacterial effect of a copper-containing titanium alloy against implant-associated infection induced by methicillin-resistant Staphylococcus aureus

Yifu Zhuang, Ling Ren, Shuyuan Zhang, Xiang Wei, Ke Yang, Kerong Dai

Acta Biomaterialia· Volume 119
Publisher page

Abstract

Implant-associated infection (IAI) induced by methicillin-resistant Staphylococcus aureus (MRSA) is a devastating complication in the orthopedic clinic. Traditional implant materials, such as Ti6Al4V, are vulnerable to microbial infection. In this study, we fabricated a copper (Cu)-containing titanium alloy (Ti6Al4V-Cu) for the prevention and treatment of MRSA-induced IAI. The material characteristics, antibacterial activity, and biocompatibility of Ti6Al4V-Cu were systematically investigated and compared with those of Ti6Al4V. Ti6Al4V-Cu provided stable and continuous Cu2+ release, at a rate of 0.106 mg/cm2/d. Its antibacterial performance against MRSA in vitro was confirmed by plate counting analysis, crystal violet staining, and scanning electron microscopic observations. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis demonstrated that Ti6Al4V-Cu suppressed biofilm formation, virulence, and antibiotic-resistance of MRSA. The in vivo anti-MRSA effect was investigated in a rat IAI model. Implants were contaminated with MRSA solution, implanted into the femur, and left for 6 weeks. Severe IAI developed in the Ti6Al4V group, with increased radiological score (9.6 ± 1.3) and high histological score (10.1 ± 1.9). However, no sign of infection was found in the Ti6Al4V-Cu group, as indicated by decreased radiological score (1.3 ± 0.4) and low histological score (2.3 ± 0.5). In addition, Ti6Al4V-Cu had favorable biocompatibility both in vitro and in vivo. In summary, Ti6Al4V-Cu is a promising implant material to protect against MRSA-induced IAI.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Orthopedic Infections and Treatments · Orthopaedic implants and arthroplasty · Bacterial biofilms and quorum sensing

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (54)

Show source-provided references
1. Infection after fracture osteosynthesis - Part I
2. Clinical presentation and treatment of orthopaedic implant-associated infection10.1111/joim.12233 ↗
3. Biomaterials approaches to treating implant-associated osteomyelitis10.1016/j.biomaterials.2015.12.012 ↗
4. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre10.1111/j.1469-0691.2006.01378.x ↗
5. Methicillin-resistant staphylococcal infections: an important consideration for orthopedic surgeons10.3928/0147-7447-20040601-12 ↗
6. Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections10.1002/jor.23656 ↗
7. Who Publishes List of Bacteria for Which New Antibiotics Are Urgently Needed
8. Prevalence and Risk Factors for Positive Nasal Methicillin-Resistant Staphylococcus aureus Carriage Among Orthopedic Patients in Korea10.3390/jcm8050631 ↗
9. Antibacterial activity of copper-bearing 316L stainless steel for the prevention of implant-related infection
10. Pathogenesis of implant-associated infection: the role of the host10.1007/s00281-011-0275-7 ↗
11. Presence of laminin receptors in Staphylococcus aureus10.1126/science.3160113 ↗
12. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material10.1093/infdis/158.4.693 ↗
13. Pathogenesis of foreign body infection: description and characteristics of an animal model10.1093/infdis/146.4.487 ↗
14. Antibacterial properties and toxicity from metallic nanomaterials10.2147/IJN.S134526 ↗
15. Antibacterial effect of copper-bearing titanium alloy (Ti-Cu) against Streptococcus mutans and Porphyromonas gingivalis10.1038/srep29985 ↗
16. Inhibition of Staphylococcus aureus biofilm by a copper-bearing 317L-Cu stainless steel and its corrosion resistance10.1016/j.msec.2016.07.050 ↗
17. Microbiological influenced corrosion resistance characteristics of a 304L-Cu stainless steel against Escherichia coli10.1016/j.msec.2014.12.004 ↗
18. An investigation of the antibacterial ability and cytotoxicity of a novel cu-bearing 317L stainless steel10.1038/srep29244 ↗
19. Effect of copper addition on mechanical properties, corrosion resistance and antibacterial property of 316L stainless steel10.1016/j.msec.2016.11.022 ↗
20. Biodegradable Mg-Cu alloy implants with antibacterial activity for the treatment of osteomyelitis: In vitro and in vivo evaluations10.1016/j.biomaterials.2016.08.031 ↗
21. In vitro study on an antibacterial Ti-5Cu alloy for medical application10.1007/s10856-016-5698-1 ↗
22. The anti-bacterial activity of titanium-copper sintered alloy against Porphyromonas gingivalis in vitro10.4012/dmj.2016-001 ↗
23. The antibacterial properties and biocompatibility of a Ti-Cu sintered alloy for biomedical application10.1088/1748-6041/9/2/025013 ↗
24. A new antibacterial titanium-copper sintered alloy: preparation and antibacterial property10.1016/j.msec.2013.06.016 ↗
25. Effect of Cu content on the antibacterial activity of titanium-copper sintered alloys10.1016/j.msec.2013.11.028 ↗
26. Optimization of mechanical properties, biocorrosion properties and antibacterial properties of as-cast Ti-Cu alloys10.1088/1748-6041/11/6/065001 ↗
27. Preliminary study on the corrosion resistance, antibacterial activity and cytotoxicity of selective-laser-melted Ti6Al4V-xCu alloys10.1016/j.msec.2016.11.126 ↗
28. Toward a Molecular Understanding of the Antibacterial Mechanism of Copper-Bearing Titanium Alloys against Staphylococcus aureus10.1002/adhm.201500712 ↗
29. Antibacterial effect of 317L stainless steel contained copper in prevention of implant-related infection in vitro and in vivo10.1007/s10856-011-4427-z ↗
30. Animal models of orthopedic implant infection10.3109/08941939809032193 ↗
31. Characterization of a rabbit model of staphylococcal osteomyelitis10.1002/jor.1100150314 ↗
32. PCR-based identification of methicillin-resistant Staphylococcus aureus strains and their antibiotic resistance profiles10.12980/APJTB.4.2014C423 ↗
33. Adjunctive mecA PCR for routine detection of methicillin susceptibility in clinical isolates of coagulase-negative staphylococci10.1128/JCM.02834-13 ↗
34. Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment10.1186/s13054-017-1801-3 ↗
35. 10 x '20 Progress–development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America10.1093/cid/cit152 ↗
36. Infectious prosthetic hip joint loosening: bacterial species involved in its aetiology and their antibiotic resistance profiles against antibiotics recommended for the therapy of implant-associated infections
37. Review of titanium surface modification techniques and coatings for antibacterial applications10.1016/j.actbio.2018.10.036 ↗
38. Antibacterial coating of implants in orthopaedics and trauma: a classification proposal in an evolving panorama10.1186/s13018-015-0294-5 ↗
39. Mechanism of antibacterial activity of copper nanoparticles10.1088/0957-4484/25/13/135101 ↗
40. The synergistic antibacterial activity and mechanism of multicomponent metal ions-containing aqueous solutions against Staphylococcus aureus10.1016/j.jinorgbio.2016.07.019 ↗
41. Copper Reduction and Contact Killing of Bacteria by Iron Surfaces10.1128/AEM.01725-15 ↗
42. Copper(II), cobalt(II) and nickel(II) complexes of juglone: synthesis, structure, DNA interaction and enhanced cytotoxicity10.1007/s10534-016-9970-0 ↗
43. Vision for medicine: Staphylococcus aureus biofilm war and unlocking key's for anti-biofilm drug development10.1016/j.micpath.2018.07.002 ↗
44. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine10.1128/IAI.00078-07 ↗
45. Rbf promotes biofilm formation by Staphylococcus aureus via repression of icaR, a negative regulator of icaADBC10.1128/JB.00913-09 ↗
46. Biofilm in implant infections: its production and regulation10.1177/039139880502801103 ↗
47. Virulence and resistance profiles of MRSA isolates in pre- and post-liver transplantation patients using microarray10.1099/jmm.0.000324 ↗
48. Methicillin-Resistant Staphylococcus aureus: Molecular Characterization
49. Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus10.1128/jb.175.6.1612-1620.1993 ↗
50. Detection of mutations in the FemXAB protein family in oxacillin-susceptible mecA-positive Staphylococcus aureus clinical isolates10.1093/jac/dkq039 ↗
51. Bacterial adherence and biofilm formation on medical implants: a review10.1177/0954411914556137 ↗
52. Bacterial resistance in biofilm-associated bacteria10.2217/fmb.15.69 ↗
53. Physicochemical properties of copper important for its antibacterial activity and development of a unified model10.1116/1.4935853 ↗
54. The Features of Copper Metabolism in the Rat Liver during Development10.1371/journal.pone.0140797 ↗